[{"NetIncomeLoss_1_Q1_USD":-69071000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":86943000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q1_USD":158000000.0,"Liabilities_0_Q1_USD":333227000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q1_USD":228000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-548000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"InventoryGross_0_Q1_USD":3989000.0,"RepaymentsOfLongTermDebt_2_Q1_USD":643000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":57338000.0,"OtherAssetsNoncurrent_0_Q1_USD":1448000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":650000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":312000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q1_USD":120852000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":0.0,"PaymentsToAcquireInvestments_2_Q1_USD":37148000.0,"AssetsCurrent_0_Q1_USD":246192000.0,"LongTermDebtCurrent_0_Q1_USD":10457000.0,"CostOfGoodsAndServicesSold_2_Q1_USD":1296000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":728000.0,"TreasuryStockShares_0_Q1_shares":793000.0,"AvailableForSaleSecurities_0_Q1_USD":114923000.0,"InterestPaidNet_2_Q1_USD":9569000.0,"TreasuryStockValue_0_Q1_USD":4843000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-69619000.0,"IncreaseDecreaseInInventories_2_Q1_USD":-254000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":57301000.0,"InventoryRawMaterials_0_Q1_USD":1154000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":5886000.0,"EarningsPerShareBasic_2_Q1_USD":-1.27,"EarningsPerShareBasic_1_Q1_USD":-0.65,"OtherNonoperatingIncomeExpense_2_Q1_USD":1591000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":633000.0,"AccountsReceivableNetCurrent_0_Q1_USD":30876000.0,"IncreaseDecreaseInDeferredRevenue_2_Q1_USD":0.0,"CommonStockValue_0_Q1_USD":108000.0,"ComprehensiveIncomeNetOfTax_2_Q1_USD":-135454000.0,"Revenues_2_Q1_USD":17162000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q1_USD":32532000.0,"TreasuryStockValueAcquiredCostMethod_1_Q1_USD":103000.0,"DebtInstrumentInterestRateStatedPercentage_0_Q1_pure":0.09,"DepreciationDepletionAndAmortization_2_Q1_USD":1806000.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_2_Q1_USD":50831000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q1_USD":-1669000.0,"RealizedInvestmentGainsLosses_2_Q1_USD":0.0,"UnamortizedDebtIssuanceExpense_0_Q1_USD":700000.0,"DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_0_Q1_USD":2000000.0,"OtherAssetsCurrent_0_Q1_USD":9461000.0,"Revenues_1_Q1_USD":9163000.0,"RoyaltyIncomeNonoperating_2_Q1_USD":267000.0,"RoyaltyIncomeNonoperating_1_Q1_USD":153000.0,"CommonStockSharesIssued_0_Q1_shares":107898000.0,"DebtInstrumentFairValue_0_Q1_USD":44700000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":63360000.0,"Goodwill_0_Q1_USD":44543000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":4258000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q1_USD":-68352000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q1_shares":106804000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":107073000.0,"InventoryWorkInProcess_0_Q1_USD":2185000.0,"LiabilitiesCurrent_0_Q1_USD":97558000.0,"AccountsPayableCurrent_0_Q1_USD":29763000.0,"InvestmentsFairValueDisclosure_0_Q1_USD":201866000.0,"InterestExpense_2_Q1_USD":10256000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q1_USD":86943000.0,"LongTermDebtNoncurrent_0_Q1_USD":234807000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":2367000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":18833000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q1_USD":-207000.0,"AdditionalPaidInCapital_0_Q1_USD":1470862000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":-10687000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":11524000.0,"NetIncomeLoss_2_Q1_USD":-135682000.0,"InterestExpense_1_Q1_USD":5125000.0,"AssetImpairmentCharges_1_Q1_USD":1600000.0,"AssetImpairmentCharges_2_Q1_USD":1600000.0,"IncreaseDecreaseInAccountsReceivable_2_Q1_USD":-25656000.0,"Assets_0_Q1_USD":322540000.0,"ShareBasedCompensation_2_Q1_USD":8690000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q1_USD":4141000.0,"CommonStockSharesAuthorized_0_Q1_shares":225000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q1_USD":33000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":25000.0,"OperatingIncomeLoss_2_Q1_USD":-127017000.0,"OperatingIncomeLoss_1_Q1_USD":-64579000.0,"PaymentsForRepurchaseOfCommonStock_2_Q1_USD":1026000.0,"InventoryNet_0_Q1_USD":3989000.0,"PreferredStockValue_0_Q1_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":322540000.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":553000.0,"OperatingExpenses_2_Q1_USD":144179000.0,"OperatingExpenses_1_Q1_USD":73742000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":862000.0,"StockholdersEquity_0_Q1_USD":-10687000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q1_USD":0.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q1_USD":726000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1477126000.0,"ResearchAndDevelopmentExpense_2_Q1_USD":112482000.0,"ShortTermInvestments_0_Q1_USD":114923000.0,"Ticker":"LXRX","CIK":"1062822","name":"LEXICON PHARMACEUTICALS, INC.","OfficialName":"Lexicon Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"332097683.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200729"}]